Rapid-SF: A Rapid Whole-Blood Screen for Soluble Fibrin Monomer
暂无分享,去创建一个
[1] M. Cupa,et al. Severe pulmonary embolism associated with air travel. , 2001, The New England journal of medicine.
[2] H. Arnesen,et al. Increased Risk of Recurrent Venous Thromboembolism during Hormone Replacement Therapy , 2000, Thrombosis and Haemostasis.
[3] C. Dempfle,et al. The Use of Soluble Fibrin in Evaluating the Acute and Chronic Hypercoagulable State , 1999, Thrombosis and Haemostasis.
[4] E. Gabazza,et al. Hemostatic molecular markers before the onset of disseminated intravascular coagulation , 1999, American journal of hematology.
[5] W. Nieuwenhuizen,et al. A New Enzyme Immunoassay for Soluble Fibrin in Plasma, with a High Discriminating Power for Thrombotic Disorders , 1999, Thrombosis and Haemostasis.
[6] B. Lämmle,et al. Performance of a New Fibrin Monomer Assay to Exclude Deep Vein Thrombosis in Symptomatic Outpatients , 1999, Thrombosis and Haemostasis.
[7] P. Hannaford,et al. Using epidemiological data to guide clinical practice: review of studies on cardiovascular disease and use of combined oral contraceptives , 1998, BMJ.
[8] Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group. , 1998, World Health Organization technical report series.
[9] World Health Organization Collaborative Study of Cardiov Contarception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study , 1995, The Lancet.
[10] J. Douketis,et al. Evaluation of a Soluble Fibrin Assay in Patients with Suspected Deep Vein Thrombosis , 1995, Thrombosis and Haemostasis.
[11] K. Huck,et al. Comparison of Immunological and Functional Assays for Measurement of Soluble Fibrin , 1995, Thrombosis and Haemostasis.
[12] M. Blombäck,et al. Soluble fibrin: A predictor for the development and outcome of multiple organ failure , 1994, American journal of hematology.
[13] M. Blombäck,et al. Laboratory methods for detecting disseminated intravascular coagulation (DIC): new aspects , 1993, Acta anaesthesiologica Scandinavica.
[14] W. Nieuwenhuizen,et al. A Rapid Monoclonal Antibody-Based Enzyme Immunoassay (EIA) for the Quantitative Determination of Soluble Fibrin in Plasma , 1992, Thrombosis and Haemostasis.
[15] P. Royston. Approximating the Shapiro-Wilk W-test for non-normality , 1992 .
[16] J. Wilson,et al. Disseminated intravascular coagulation in liver cirrhosis. , 1992, Journal of hepatology.
[17] C. Hosius,et al. Determination of soluble fibrin: a comparison of four different methods. , 1992, Thrombosis research.
[18] S. Halvorsen,et al. Comparison of methods for detecting soluble fibrin in plasma. An in vitro study. , 1990, Thrombosis research.
[19] H. Köstering,et al. Determination of Soluble Fibrin by Turbidimetry of its Protamine Sulphate-Induced Paracoagulation , 1989, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.
[20] J. Usero,et al. The fibrinogen-fibrin complex: stoichiometry and negative cooperativity. , 1985, Thrombosis research.
[21] P. Wiltzius,et al. Fibrin aggregation before sol-gel transition. , 1982, Biophysical journal.
[22] F. Brosstad,et al. The fibrin-solubilizing effect of fibrinogen as studied by light scattering. , 1979, Thrombosis research.
[23] E. Brass,et al. Fibrin Formation: The Role of the Fibrinogen-Fibrin Monomer Complex , 1976, Thrombosis and Haemostasis.
[24] J. Hawiger,et al. Electron Microscopy of Fibrin‐like Precipitate Formed during the Paracoagulation Reaction between Soluble Fibrin Monomer Complexes and Protamine Sulphate , 1969, British journal of haematology.